|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Favism | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glucosephosphate Dehydrogenase Deficiency | |||||
| Glycogen Storage Disease Type I | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia | |||||
| Anemia, Hemolytic | |||||
| Anemia, Hemolytic, Congenital | |||||
| Carbohydrate Metabolism, Inborn Errors | |||||
| Disorders of Environmental Origin | |||||
| Food Poisoning | |||||
| Genetic Diseases, Inborn | |||||
| Glycogen Storage Disease | |||||
| Hematologic Diseases | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Plant Poisoning | |||||
| Poisoning | |||||
| 4 | Interventions listed in this trial | ||||
| Primaquine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antimalarials | |||||
| Antiparasitic Agents | |||||
| Antiprotozoal Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Walter Reed Army Institute of Research (WRAIR) | |||||